Noaber

Venture capital

UncertainLast verified 7 Nov 2026

Healthcare impact investor backing (pre-)seed startups that contribute to healthy living and disease management across Benelux, Nordics, DACH, and the UK.

0 deals in the last 24 months. Taken from its own website.

Key facts

Stages: Pre-seed, Seed, Series A
Sectors: Healthtech, Social impact
Eligible countries: Austria, Belgium, Switzerland, Germany, Denmark, Finland, United Kingdom, Iceland, Luxembourg, Netherlands, Norway, Sweden
Provider based in: Netherlands
Timing: Rolling applications
Focus: healthy and active living; screening and diagnostics; smart disease management; healthcare impact
How to apply: Apply route unknown
Source: https://www.noaber.com/en/investments

Recent deals

No deals in our data for the last 24 months.

Evidence

Short excerpts from the sources, in their original language, that back the facts above.

KindWe invest on solutions that positively contribute to healthy and active living, measured by the Quadruple Aim framework.https://www.noaber.com/en/investments
SectorsThis includes solutions that spur positive choices for healthy lifestyles, guide professionals /patients in screening/diagnostics, allow for smart disease…https://www.noaber.com/en/investments
StagesWe primarily focus on (pre-)seed companies that are based in the Benelux, Nordics, DACH or UK regions.https://www.noaber.com/en/investments

Status history

7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
6 Nov 2026: Rolling (first extraction)

Something wrong or out of date? Report an error.

Work at Noaber? Claim this profile to confirm what you invest in.